Rivastigmine Tartrate
NDC 0904-7107, Rivastigmine Tartrate, capsule, from Major Pharmaceuticals.
- Product NDC
- 0904-7107
- Status
- Listed
- Labeler
- Major Pharmaceuticals
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204572
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0904-7107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE TARTRATE1.5 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0904-7107-61 | 00904710761 | 100 BLISTER PACK in 1 CARTON (0904-7107-61) / 1 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/39aadc39-0f4f-44f7-88de-83a0ea2ac332NADAC price for package 00904710761
GET /v1/drugs/nadac/00904710761
Use it
Look up 0904-7107 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0904-7107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0904-7107. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.